Implexis

Biotechnology · CRO & CDMO Services
Venture roundlatest round · Jul 2026 · 4 mo ago
2backers · UCL Technology Fund, Haatch
2team · UK accounts · Mar 2026
2025founded

Overview

Accelerate your pharmaceutical formulation development with our proprietary optimisation algorithm.

Funding and backers

Latest round
Venture round
Jul 2026 · 4 mo ago
Team
2
UK accounts · Mar 2026
Backers
2
UCL Technology Fund, Haatch
The money's age
Fresh money
4 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 9 Raised a round Venture round Mar 6, 2025 Founded per the company register
Tractionpublic signals, read monthly
Web presence
top 31%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity IMPLEXIS LTD Companies House
Registered 6 Mar 2025
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
PersistSeries A $12M · 17 mo ago · Founded 2022 · 51-200 employees
AI-driven formulation development with robotic execution. Hit your QTPP faster.
Marama Labs51-200 employees · 2 roles
CloudSpec™ quantifies therapeutic content of nano-formulations, such as RNAin LNPs, in seconds with a unique accurate and precise…
SciLeadsVenture round · 8 mo ago · Founded 2016 · 51-200 employees · 2 roles
On a mission to accelerate discovery. Launched in 2016, SciLeads is trusted by hundreds of scientific companies globally to accelerate…
CodisFounded 1993 · 51-200 employees · 6 roles
Codis combines particle engineering, spray drying, and formulation expertise to solve bioavailability and manufacturing challenges…
Artis BioSolutions51-200 employees · 5 roles
Artis BioSolutions unites proprietary enzymatic synthetic DNA with advanced therapy development and GMP manufacturing across the US and EU.
Axplora2 roles
Axplora is a global API manufacturer and pharmaceutical CDMO delivering complex API development, manufacturing and advanced technologies.

Financials

Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
67 portfolio companies: Synthesia, Intract Pharma, Wellspring and 64 more
HaatchVia a fund
169 portfolio companies: Visitone, Taughtbyhumans, Thinkmodem and 166 more

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London United Kingdom
HQ
CONTACT US
1-10 est. staff
London WC1B 4DA, United Kingdom
company site